Sunday, December 02, 2012 12:59:10 PM
http://www.sec.gov/Archives/edgar/data/728387/000135982012000019/xslF345X03/primary_doc.xml
Recent CATX News
- Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/31/2024 11:00:00 AM
- Perspective Therapeutics to Participate in Upcoming Investor Conferences in November • GlobeNewswire Inc. • 10/29/2024 11:00:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/24/2024 06:02:10 PM
- Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine • GlobeNewswire Inc. • 10/23/2024 11:00:00 AM
- Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey • GlobeNewswire Inc. • 10/16/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 12:31:59 PM
- Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research • GlobeNewswire Inc. • 10/11/2024 12:30:00 PM
- Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research • GlobeNewswire Inc. • 10/10/2024 09:14:15 PM
- Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day • GlobeNewswire Inc. • 10/07/2024 11:00:00 AM
- Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine • GlobeNewswire Inc. • 09/30/2024 11:00:00 AM
- Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024 • GlobeNewswire Inc. • 09/10/2024 11:00:00 AM
- Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma • GlobeNewswire Inc. • 09/05/2024 11:00:00 AM
- Perspective Therapeutics to Participate in Upcoming Investor Conferences in September • GlobeNewswire Inc. • 08/28/2024 11:00:00 AM
- Rumble Shares Up 7% in Premarket After 27% Q2 Revenue Surge; More on Earnings • IH Market News • 08/13/2024 09:39:29 AM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 2Q 2024 Results • GlobeNewswire Inc. • 08/12/2024 08:05:59 PM
- U.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices Climb • IH Market News • 08/12/2024 09:47:41 AM
- Perspective Therapeutics to Participate at Upcoming Investor Conferences in August • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/22/2024 11:00:00 AM
- Perspective Therapeutics Announces Inclusion in the Russell 3000® Index • GlobeNewswire Inc. • 06/12/2024 11:00:00 AM
- Perspective Therapeutics Announces 1-for-10 Reverse Stock Split • GlobeNewswire Inc. • 06/11/2024 11:00:00 AM
- Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting • GlobeNewswire Inc. • 06/10/2024 08:10:00 PM
- Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 05/24/2024 12:01:41 PM
- Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024 • GlobeNewswire Inc. • 05/20/2024 11:00:03 AM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results • GlobeNewswire Inc. • 05/15/2024 11:00:00 AM
- Perspective Therapeutics to Participate at Upcoming May Investor Conferences • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM